Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | 0.00% | 0.00% | 0.00% |
Jan. 26 | Optimind Pharma Reaches Agreement On Debenture Conversion | MT |
Jan. 10 | Optimind Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023 | CI |
Quotes 5-day view
Delayed Quote Canadian Securities Exchange2024-05-02 | |
---|---|
Last | 0.005 $ |
Volume | 3 000 |
Change | +∞% |
Opening | 0.01 |
High | 0.01 |
Low | 0.01 |
Performance
6 months | -66.67% | ||
1 year | -80.00% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Bio Therapeutic Drugs
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
0.00% | 0.00% | 0.00% | -80.00% | 358K | ||
-0.49% | +0.62% | -1.65% | +15.64% | 103B | ||
+3.78% | +5.27% | +6.75% | +17.43% | 101B | ||
+0.63% | +4.64% | +6.38% | +1.42% | 23.07B | ||
+2.55% | +6.38% | -12.60% | -16.95% | 22.23B | ||
+4.78% | +1.34% | -5.57% | -27.17% | 18.05B | ||
-2.02% | +3.73% | -39.98% | -35.33% | 17.18B | ||
+3.50% | +9.05% | -10.17% | -38.50% | 16.94B | ||
-2.24% | +1.50% | +6.12% | +35.17% | 14.07B | ||
-0.21% | +2.54% | +35.47% | +5.61% | 12.35B | ||
-0.82% | +10.02% | +307.09% | +260.76% | 8.35B | ||
+0.06% | +3.05% | +12.03% | +64.09% | 8.06B | ||
+4.43% | +3.40% | -23.67% | -30.03% | 8.36B | ||
-0.04% | +1.26% | +0.47% | +37.89% | 7.73B | ||
-4.12% | +7.55% | -52.84% | -69.98% | 7.75B | ||
+1.32% | +7.48% | +2.79% | +37.22% | 7.02B | ||
Average | +0.64% | +4.71% | +14.41% | +11.08% | ||
Weighted average by Cap. | +1.47% | +3.90% | +5.38% | +11.46% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Last transactions
Date | Price | Volume | Daily volume |
---|
Monthly variations
Annual change
2024 | 0.00% | ||
2023 | -83.33% | ||
2022 | -80.00% |
- Stock Market
- Equities
- OMND Stock
- Quotes Optimind Pharma Corp.